Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin G receptors (Fc gamma receptors, or FcγRs) are a family of cell surface glycoproteins found on various immune cells. They play a central role in linking humoral and cellular immunity by binding to the Fc region of IgG antibodies and mediating diverse immune responses. They trigger effector functions in immune cells, including phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), degranulation, cytokine production, antigen presentation, and regulation of inflammatory responses. Human classical FcγRs are divided into three main families: FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16). Polymorphisms in FCGR genes can impact susceptibility to autoimmune diseases, response to therapeutic antibodies, and infection risk.
Modulation of immune cell activity through binding to IgG antibodies and triggering downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin G receptor FCGRs.